Latest News and Press Releases

Dublin, March 03, 2025 (GLOBE NEWSWIRE) -- The "Neurology Market: Research Overview" report has been added to ResearchAndMarkets.com's offering.The Neurology Market was valued at USD 67.3 Billion...

New York, United States, April 08, 2024 (GLOBE NEWSWIRE) -- Dementia is a term used to describe a group of symptoms that significantly impair memory, reasoning, and social abilities. The symptoms...

Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Neurology Contract Research Organization Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology,...

Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Global Neurology Patient Monitoring Market by Device (Cerebral Oximeters, Electroencephalography Monitors, Intracranial Pressure Monitors), Disease...

WOBURN, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Axial Therapeutics, a clinical-stage biotechnology company dedicated to the development of gut-targeted, small molecule therapeutics for neurological...

Dublin, June 21, 2023 (GLOBE NEWSWIRE) -- The "Nerve Repair and Regeneration Devices: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...

–Grant supports the continued preclinical development of AX-5006, a small molecule, gut-restricted amyloid inhibitor for symptomatic treatment and modification of disease in PD– –IND-enabling...

Dublin, June 05, 2023 (GLOBE NEWSWIRE) -- The "Immunoassay for Neurological Biomarkers Market Size, Share & Trends Analysis Report By Product, By Disease (Alzheimer's Disease, Parkinson's...

– Phase 2b clinical trial for AB-2004 in autism irritability ongoing and enrollment anticipated to be complete by end of 2023 – – IND-enabling studies ongoing for Parkinson’s Disease development...

Horsham, PA, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, has partnered with a leading biopharmaceutical organization focused on Parkinson’s Disease...